Androgen Deprivation Therapy and Cardiovascular Risk
Author(s) -
Sanoj Punnen,
Matthew R. Cooperberg,
Natalia Sadetsky,
Peter R. Carroll
Publication year - 2011
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2011.35.1494
Subject(s) - medicine , propensity score matching , androgen deprivation therapy , prostate cancer , watchful waiting , proportional hazards model , oncology , cancer
The potential association between androgen deprivation therapy (ADT) and cardiovascular mortality (CVM) remains controversial. This study assessed mortality outcomes in a large national registry to further elucidate the association between treatment selection and cause of mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom